Down-regulated GFAPα: a major player in heavy metal induced astrocyte damage.
Exposure to a mixture of As, Pb and Cd induces apoptosis and morphological alterations in the cortical astrocytes of rat brain. The levels of the glial fibrillary acidic protein (GFAP) undergo a reduction. The GFAP exists in several isoforms, viz., α, β, κ, δ and ϵ. However, contribution of the isoforms towards astrocyte damage is not understood. We investigated the effect of the metal mixture (MM) on the expression profiles of mRNAs encoding the GFAP isoforms in astrocytes. The MM was administered in drinking water to developing rats till postnatal day (PD) 60. We observed a fall (10.20 ± 1.04%, 18.91 ± 2.12% and 30.26 ± 3.21% at PD24, PD45 and PD60 respectively) in GFAPα. This may have been compensated by a rise in β, κ, and ϵ. The GFAPδ remained unchanged. To determine the role of the GFAPα, we silenced its gene using SiRNA technology in the rat primary astrocytes. We observed a 23.73 ± 1.56% increase in the number of apoptotic cells. The cleaved PARP and Bax levels increased by 2.48 ± 0.14-fold and 3.73 ± 0.23-fold respectively, and the Bcl-2 and Bcl-xl decreased by 2.38 ± 0.08-fold and 1.76 ± 0.09-fold respectively. The change was comparable to the cells treated with MM. Moreover, silencing the GFAPα gene induced a reduction in the area (6.19 ± 0.18-folds), perimeter (12.65 ± 1.68-folds) and the number of processes (5.88 ± 1.5-folds) in the astrocytes, which closely matched the MM-treated ones. Taken together, these observations are the first to show that MM disturbs the composition of the GFAP isoforms, and a suppressed GFAPα promotes apoptosis in the matured rat astrocytes.
Department of Biochemistry, Jamia Hamdard (Hamdard University) , New Delhi 110062 , India. asitrai1@gmail.com
Asit
A
Rai
Shailendra Kumar
SK
Maurya
Rolee
R
Sharma
Shakir
S
Ali
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D018053:Arsenites / Q000633:toxicity*; D001253:Astrocytes / Q000187:drug effects* / Q000473:pathology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D019256:Cadmium Chloride / Q000633:toxicity*; D015536:Down-Regulation / Q000187:drug effects; D004338:Drug Combinations; D005260:Female; D020868:Gene Silencing; D005904:Glial Fibrillary Acidic Protein / Q000235:genetics / Q000378:metabolism*; D008297:Male; D018811:Maternal Exposure; D009942:Organometallic Compounds / Q000633:toxicity*; D011247:Pregnancy; D020033:Protein Isoforms; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics; D051381:Rats; D017670:Sodium Compounds / Q000633:toxicity*; D014162:Transfection / Q000379:methods
D018053:Arsenites; D004338:Drug Combinations; D005904:Glial Fibrillary Acidic Protein; D009942:Organometallic Compounds; D020033:Protein Isoforms; D034741:RNA, Small Interfering; D017670:Sodium Compounds; C017947:sodium arsenite; D019256:Cadmium Chloride; C008261:lead acetate